Gabelli Funds’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Gabelli Funds’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-195,637	Closed	-$14.7M	–	1437
2022 Q2	$14.7M	Buy	+195,637	New	+$8.69M	0.11%	251

Gabelli Funds's TPTX Position: Q3 2022 in Review

Gabelli Funds sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 195,637 shares — an estimated $14.7M sold.

Gabelli Funds first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $14.7M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Gabelli Funds reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Gabelli Funds sold 195,637 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $14.7M.
Gabelli Funds first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Gabelli Funds's Turning Point Therapeutics, Inc. Common Stock position peaked at $14.7M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Gabelli Funds's 13F filing for Q3 2022, filed 10 Nov 2022.